HIV Postexposure Prophylaxis (PEP) in a Nigerian Tertiary Health Institution

Abstract

Background: Use of PEP drugs is useful in preventing seroconversion following accidental occupational or nonoccupational exposures, thereby limiting further spread of HIV. Objective: This study aims to evaluate the clinicodemographic characteristics of patients accessing PEP services in a tertiary health institution. Study Design: This was a retrospective review of patients who obtained postexposure prophylaxis from the HIV clinic of a University Teaching Hospital in Nigeria. Results: A total of 116 clients sought for PEP services during the study period. The commonest setting of exposure was needle injury (44.8%). Half of the clients presented within 24 hours following exposure. Being a male and knowing HIV status of source patient independently increased the likelihood of early presentation following exposure (P < .05). None of the patients that obtained the PEP drugs came for follow-up visits. Conclusion/Recommendation: Late presentation for PEP services following exposure means that more awareness needs to be created to facilitate early presentation.

Keywords

postexposure prophylaxis HIV Nigeria

References

Jost J. Post-exposure HIV prevention within and outside the hospital. Ther Umsch. 1998;55(5):289-294.

Young TN , Arens FJ , Kennedy GE , Laurie JW , Rutherford G. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure . Cochrane Database Syst Rev. 2007 ;(1): CD002835.

National guidelines for HIV and AIDS Treatment and Care in adolescents and adults. Nigeria: Federal Ministry of Health Abuja; 2007.

Bryant J. , Baxter L. , Hird S. Non-occupational post exposure prophylaxis for HIV: a systematic review . Health Techno Assess. 2009;13(14):iii, ix-x, 1-60.

Fong C. Post-exposure prophylaxis for HIV infection after sexual assault: when is it indicated? Emerg Med J. 2001;18(4):242-245.

Ojoh R. , Simpet W. , Agaba P. , Agbaji O. , Idoko J. Profile of post exposure prophylaxis in APIN-PLUS Jos Nigeria. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia.

Siika AM , Nyandiko WM , Mwangi A. , et al. The structure and outcomes of a HIV postexposure prophylaxis program in a high HIV prevalence setup in western Kenya. J Acquir Immune Defic Syndr. 2009;51(1):47-53.

Kim JC , Askew I. , Muvhango L. , et al. Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: the Refentse intervention study. BMJ . 2009;338:b515. doi: 10.1136/ bmj.b515.

Olowookere SA , Fatiregun AA Human immunodeficiency virus postexposure prophylaxis at Ibadan, Nigeria. J Int Assoc Physicians AIDS Care (Chic Ill). 2010;9(3):187-190. Epub 2010 Mar 31.

10.

Erhabor O. , Ejele OA , Nwauche CA Epidemiology and management of occupational exposure to blood borne viral infections in a resource poor setting: the case for availability of post exposure prophylaxis. Niger J Clin Pract. 2007;10(2):100-104.

11.

2008 National HIV Sero-Prevalence Sentinel Survey among the Antenatal Clinic Attendees. Nigeria: Federal Ministry of Health.

12.

Gutierrez EB , Lopes MH , Yasuda MA Accidental exposure to biological material in healthcare workers at a university hospital: evaluation and follow-up of 404 cases. Scand J Infect Dis. 2005; 37(4):295-300.